Baseball Legend Ken Griffey Sr. Joins Chicago’s Largest Prostate Cancer Walk & Run Set On 9/11
CHICAGO, IL – Registration is open for the 12th Annual SEA Blue Chicago Prostate Cancer Walk & Run at www.seablueprostatewalk.org. Blue is to prostate cancer as pink is to breast cancer; and “SEA” represents the Support, Education & Advocacy that the event provides to the prostate cancer community. Money raised will help fund the work of Us TOO International (www.ustoo.org), a nonprofit that provides educational resources and support services to the prostate cancer community at no charge.
The SEA Blue event will be on Sunday, September 11, 2016, from 8 a.m. to noon, in Lincoln Park at LaSalle and Stockton on Chicago’s lakefront. In addition to the tradition of honoring prostate cancer survivors as warriors and guardians of the next generation, the event will thank local first responders in recognition of 9/11. Prostate cancer survivor and Baseball Hall-of-Famer Ken Griffey Sr. will also be there to remind men to speak up about prostate cancer.
The event features a 5K race certified by the Chicago Area Runners Association (CARA), along with a walk through Lincoln Park for individuals and teams to help raise awareness for prostate cancer, the most common cancer among men. Physicians will provide disease education presentations and free PSA testing for prostate cancer will be available. The event includes a performance by the Jesse White Tumblers, a DJ, live music, free lunch and snacks, a “Family Fun Zone” for kids with face painting, “dress-up in blue” photo area, temporary tattoos, special t-shirts, balloons, a bounce house and more.
“There’s an urgent need for prostate cancer support, education and advocacy here in Chicagoland and across the country,” said Us TOO CEO Chuck Strand. “Within the next eight years, the number of men diagnosed with prostate cancer is estimated to increase from nearly three million today to 4.2 million as baby boomers age. Every one of these men and his loved ones will need information to make smart choices for minimizing the impact of the disease while maximizing the quality of life.”